G Medical Innovations Holdings Ltd (GMVDF)
OTCMKTS
· Delayed Price · Currency is USD
0.0010
+0.0009 (900.00%)
Sep 19, 2024, 9:30 AM EDT
GMVDF Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2017 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '22 Dec 31, 2022 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2017 - 2015 |
| Revenue | 4.42 | 4.42 | 4.96 | 4.9 | 5.53 | 3.06 | Upgrade
|
| Revenue Growth (YoY) | -10.91% | -10.91% | 1.24% | -11.33% | 80.47% | 2709.17% | Upgrade
|
| Cost of Revenue | 3.64 | 3.64 | 3.45 | 4.23 | 5.75 | 2.99 | Upgrade
|
| Gross Profit | 0.78 | 0.78 | 1.51 | 0.67 | -0.22 | 0.07 | Upgrade
|
| Selling, General & Admin | 20.61 | 20.61 | 10.8 | 11.65 | 10 | 12.82 | Upgrade
|
| Research & Development | 2.29 | 2.29 | 1.68 | 1.32 | 2.55 | 4.15 | Upgrade
|
| Operating Expenses | 28.19 | 28.19 | 12.48 | 12.97 | 12.56 | 17.25 | Upgrade
|
| Operating Income | -27.41 | -27.41 | -10.97 | -12.3 | -12.78 | -17.18 | Upgrade
|
| Interest Expense | -4.08 | -4.08 | -0.82 | -0.46 | -1.4 | -0.99 | Upgrade
|
| Interest & Investment Income | - | - | - | - | - | 0.16 | Upgrade
|
| Other Non Operating Income (Expenses) | 17.55 | 17.55 | -2.81 | 0.06 | -2.19 | 0.7 | Upgrade
|
| Pretax Income | -13.94 | -13.94 | -14.59 | -12.71 | -16.37 | -17.32 | Upgrade
|
| Income Tax Expense | 0.02 | 0.02 | -0 | -0.02 | -0.86 | -0.35 | Upgrade
|
| Earnings From Continuing Operations | -13.96 | -13.96 | -14.59 | -12.69 | -15.51 | -16.98 | Upgrade
|
| Minority Interest in Earnings | 0.44 | 0.44 | 0.13 | 0.15 | 0.5 | 0.71 | Upgrade
|
| Net Income | -13.52 | -13.52 | -14.46 | -12.54 | -15.01 | -16.26 | Upgrade
|
| Net Income to Common | -13.52 | -13.52 | -14.46 | -12.54 | -15.01 | -16.26 | Upgrade
|
| Shares Outstanding (Basic) | 1 | 1 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 1 | 1 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | 122.18% | 122.18% | 54.45% | 70.77% | 12.15% | 47.52% | Upgrade
|
| EPS (Basic) | -18.76 | -18.76 | -44.56 | -59.68 | -122.04 | -148.26 | Upgrade
|
| EPS (Diluted) | -18.76 | -18.76 | -44.56 | -59.68 | -122.04 | -148.26 | Upgrade
|
| Free Cash Flow | -20.6 | -20.6 | -12.04 | -5.15 | -6.73 | -17.82 | Upgrade
|
| Free Cash Flow Per Share | -28.58 | -28.58 | -37.12 | -24.53 | -54.68 | -162.47 | Upgrade
|
| Gross Margin | 17.74% | 17.74% | 30.42% | 13.61% | -4.04% | 2.22% | Upgrade
|
| Operating Margin | -620.14% | -620.14% | -221.08% | -251.02% | -231.25% | -561.20% | Upgrade
|
| Profit Margin | -305.90% | -305.90% | -291.41% | -255.84% | -271.68% | -531.09% | Upgrade
|
| Free Cash Flow Margin | -466.06% | -466.06% | -242.77% | -105.18% | -121.72% | -582.01% | Upgrade
|
| EBITDA | -26.65 | -26.65 | -9.93 | -10.88 | -9.91 | -14.51 | Upgrade
|
| EBITDA Margin | - | - | -200.16% | -222.08% | -179.32% | - | Upgrade
|
| D&A For EBITDA | 0.76 | 0.76 | 1.04 | 1.42 | 2.87 | 2.68 | Upgrade
|
| EBIT | -27.41 | -27.41 | -10.97 | -12.3 | -12.78 | -17.18 | Upgrade
|
| EBIT Margin | - | - | -221.08% | -251.02% | -231.25% | - | Upgrade
|
| Revenue as Reported | 4.42 | 4.42 | 4.96 | 4.9 | 5.53 | 3.06 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.